Carregant...
Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
PURPOSE OF REVIEW: In humans, only one independent immunologic correlate of reduced risk of HIV infection has been identified: a robust antibody (Ab) response to the V1V2 domain of the gp120 envelope (Env) protein. In recent years, the presence and level of V1V2-specific Abs has also been correlated...
Guardat en:
| Publicat a: | Curr Opin HIV AIDS |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542703/ https://ncbi.nlm.nih.gov/pubmed/30994501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0000000000000551 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|